Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Mar. (CADTH Optimal Use Report, No. 1.2D.)
Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study [Internet].
Show details- 1.
- Bashore TM, Granger CB, Hranitzky P. Heart disease. In: McPhee SJ, Papadakis MA, Tierney LM Jr, editors. Current medical diagnosis & treatment. 47th ed. New York: McGraw Hill Medical; 2008. pp. 280–369. Chapter 10.
- 2.
- Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference 2004: atrial fibrillation [Internet]. Ottawa: The Society; 2004. [cited 2011 Apr 26]. Available from: http://www
.ccs.ca/download /consensus_conference /consensus_conference_archives /2004_Atrial_Fib_full .pdf. - 3.
- Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000 Jan 10;160(1):41–46. [PubMed: 10632303]
- 4.
- Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008 Jun;133(6 Suppl):160S–198S. [PubMed: 18574265]
- 5.
- Health Canada. Drug product database online query [Internet]. Ottawa: Health Canada, Therapeutic Products Directorate; 2009. [cited 2011 Apr 25]. Available from: http://webprod
.hc-sc .gc.ca/dpd-bdpp/index-eng.jsp. - 6.
- Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest [Internet]. Jun, 2008. [cited 2011 May 17]. pp. 546S–592S. Available from: http://chestjournal
.chestpubs .org/content/133/6_suppl/546S .full.pdf+html. [PubMed: 18574273] - 7.
- Poon IO, Lal L, Brown EN, Braun UK. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007 Feb;32(1):21–29. [PubMed: 17286786]
- 8.
- Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thromb Thrombolysis. 2007 Apr;23(2):83–91. [PubMed: 17221328]
- 9.
- Tsuyuki RT, Bungard T, Grant CM, Ackman ML. Anticoagulation clinics in North America: operational insights. Can J Hosp Pharm. 2008 Jul;61(4):245–246.
- 10.
- UW Health. Ambulatory guideline for warfarin management dosing tool [Internet]. Version 2.0. [Madison (WI)]: [University of Wisconsin Hospital and Clinics]; 2010. [cited 2011 Aug 24]. Available from: http://www
.uwhealth.org /files/uwhealth/docs /pdf3/Warfarin_Dosing_Protocol.pdf. - 11.
- WarfarinDosing.org [Internet]. Saint Louis (MO): Washington University in St. Louis; 2011. [cited 2011 Aug 24]. Available from: http://www
.warfarindosing .org/Source/Home.aspx. - 12.
- Dawn AC anticoagulation software for warfarin and coumadin clinic management [Internet]. Milnthorpe (UK): 4S Information Systems; 2010. [cited 2011 Aug 24]. Available from: http://www
.4s-dawn.com/dawnac/index.htm. - 13.
- Wild D, Murray M, Donatti C. Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain. Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):467–474. [PubMed: 19817530]
- 14.
- Dantas GC, Thompson BV, Manson JA, Tracy CS, Upshur RE. Patients' perspectives on taking warfarin: qualitative study in family practice. BMC Fam Pract [Internet]. Jul 21, 2004. [cited 2011 Jul 22]. p. 15. Available from: http://www
.ncbi.nlm.nih .gov/pmc/articles/PMC509246. [PMC free article: PMC509246] [PubMed: 15268764] - 15.
- Lip GY, Agnelli G, Thach AA, Knight E, Rost D, Tangelder MJ. Oral anticoagulation in atrial fibrillation: a pan-European patient survey. Eur J Intern Med. 2007 May;18(3):202–208. [PubMed: 17449392]
- 16.
- Pradhan AA, Levine MA. Warfarin use in atrial fibrillation: a random sample survey of family physician beliefs and preferences. Can J Clin Pharmacol. 2002;9(4):199–202. [PubMed: 12584578]
- 17.
- Partington SL, Abid S, Teo K, Oczkowski W, O'Donnell MJ. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy. Thromb Res. 2007;120(5):663–669. [PubMed: 17434577]
- 18.
- Gattellari M, Worthington J, Zwar N, Middleton S. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke [Internet]. Jan, 2008. [cited 2011 Jul 11]. pp. 227–230. Available from: http://stroke
.ahajournals .org/content/39/1/227.full.pdf+html. [PubMed: 18048861] - 19.
- Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, de Reuck J, et al. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol [Internet]. Jun, 2004. [cited 2011 Jul 28]. pp. 798–806. Available from: http://www
.ncbi.nlm.nih .gov/pmc/articles/PMC1884529. [PMC free article: PMC1884529] [PubMed: 15151526] - 20.
- Anderson N, Fuller R, Dudley N. 'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation. QJM [Internet]. May, 2007. [cited 2011 Jul 8]. pp. 263–269. Available from: http://qjmed
.oxfordjournals .org/content/100/5/263 .full.pdf+html. [PubMed: 17389657] - 21.
- Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Warfarin use in the elderly: the nurses' perspective. Aust J Adv Nurs. 2006 Mar;23(3):19–25. [PubMed: 16568875]
- 22.
- Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing. 2011 Nov;40(6):675–683. [PubMed: 21821732]
- 23.
- Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Med J Aust [Internet]. Feb 19, 2007. [cited 2011 Jul 8]. pp. 175–180. Available from: https://www
.mja.com.au /sites/default/files /issues/186_04_190207/baj10154_fm.pdf. [PubMed: 17309417]
- REFERENCES - Warfarin Management in Patients with Atrial Fibrillation — Current ...REFERENCES - Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study
- Evidence - Internet-Delivered Cognitive Behavioural Therapy for Post-Traumatic S...Evidence - Internet-Delivered Cognitive Behavioural Therapy for Post-Traumatic Stress Disorder: Recommendations
- Study Characteristics, Methodological Assessment, Methodologies for Patients’ Pe...Study Characteristics, Methodological Assessment, Methodologies for Patients’ Perspectives and Experiences Review - HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment
- Characteristics of Existing Published Model-Based Economic Evaluations - HPV Tes...Characteristics of Existing Published Model-Based Economic Evaluations - HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment
- Patients’ Perspectives and Experiences Review — Shift of Balance of Factors - HP...Patients’ Perspectives and Experiences Review — Shift of Balance of Factors - HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment
Your browsing activity is empty.
Activity recording is turned off.
See more...